Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Browse Other Projects on Experiment
Related Projects
Part 2: Can low carbohydrate ketogenic diets inhibit cancers?
We've identified that ketone bodies, i.e. fuels in the bloodstream that result from a very low carbohydrate...
Target-based drug discovery for coronavirus disease 2019
Therapeutics in any modality to combat Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections...
Finding a Cure for Mitochondrial DNA Diseases through COX2 Variations to Restore Cell Function
Inherited and acquired mutations in the mitochondrial DNA can lead to several debilitating diseases, including...